nimodipine has been researched along with ANS (Autonomic Nervous System) Diseases in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment of vasospasms during endovascular stroke treatment (EST) with intra-arterial nimodipine (NM) is routinely performed." | 8.31 | Effect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment - angiographic resolution and infarct growth in follow-up imaging. ( Bendszus, M; Chen, M; Do, TD; Jesser, J; Möhlenbruch, MA; Potreck, A; Schönenberger, S; Seker, F; Vollherbst, D; Weyland, CS, 2023) |
| "The treatment of vasospasms during endovascular stroke treatment (EST) with intra-arterial nimodipine (NM) is routinely performed." | 4.31 | Effect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment - angiographic resolution and infarct growth in follow-up imaging. ( Bendszus, M; Chen, M; Do, TD; Jesser, J; Möhlenbruch, MA; Potreck, A; Schönenberger, S; Seker, F; Vollherbst, D; Weyland, CS, 2023) |
| "Poor outcomes in Subarachnoid Hemorrhage (SAH) are in part due to a unique form of secondary neurological injury known as Delayed Cerebral Ischemia (DCI)." | 3.01 | Cortical Spreading Depolarization and Delayed Cerebral Ischemia; Rethinking Secondary Neurological Injury in Subarachnoid Hemorrhage. ( Bischof, H; Diedrich, D; Gomez, F; Laudanski, K; Mehra, A, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jesser, J | 1 |
| Potreck, A | 1 |
| Vollherbst, D | 1 |
| Seker, F | 1 |
| Chen, M | 1 |
| Schönenberger, S | 1 |
| Do, TD | 1 |
| Bendszus, M | 1 |
| Möhlenbruch, MA | 1 |
| Weyland, CS | 1 |
| Mehra, A | 1 |
| Gomez, F | 1 |
| Bischof, H | 1 |
| Diedrich, D | 1 |
| Laudanski, K | 1 |
1 review available for nimodipine and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Cortical Spreading Depolarization and Delayed Cerebral Ischemia; Rethinking Secondary Neurological Injury in Subarachnoid Hemorrhage.
Topics: Autonomic Nervous System Diseases; Brain; Brain Ischemia; Cerebral Infarction; Humans; Nimodipine; S | 2023 |
1 other study available for nimodipine and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Effect of intra-arterial nimodipine on iatrogenic vasospasms during endovascular stroke treatment - angiographic resolution and infarct growth in follow-up imaging.
Topics: Autonomic Nervous System Diseases; Brain Ischemia; Endovascular Procedures; Follow-Up Studies; Human | 2023 |